Pulse - Value Added
FRACTIONAL CRO · MARYLAND-BASED, NATIONWIDE · $0→$200M

Kory White

RevOps & Revenue Leadership

Get a free 30-minute revenue checkup — Kory reviews your pipeline and forecast, then names the 1–2 fixes that move revenue fastest. 25 yrs scaling teams $0→$200M.

Free 30-min revenue checkup →
Hire a Fractional CROHow We Help?LinkedInRésuméCRO Syndicate
← Library
Knowledge Library · pulse-tools
13/13 Gate✓ IQ Certified10/10?

How does a fractional CRO build pipeline for a medical device company in 2027?

Pulse ToolsHow does a fractional CRO build pipeline for a medical device company in 2027?
📖 1,937 words🗓️ Published Jul 21, 2026 · Updated Jul 20, 2026

A fractional CRO builds pipeline for a medical device company in 2027 by combining deep regulatory and clinical knowledge with modern revenue operations, not by cold-calling surgeons. Expect total monthly investment in the range of a retainer for 8–15 days of work, depending on the company's stage (pre-revenue vs. 5M+ ARR), the complexity of the device (Class II vs. Class III), and whether the role includes hands-on deal execution or pure strategy. The work is highly specialized and requires both a CRO who has sold into hospital systems and a founder who is willing to let go of "founder-led sales" control. title: How to evaluate a fractional CRO for medical device pipeline building

a: Hire a fractional CRO b: Hire a full-time VP of Sales

type: tip A fractional CRO with prior medical device experience is worth paying a premium for. They will already know the difference between selling to a community hospital vs. a major academic medical center, and they won't waste time on GPO contracts that don't fit your device's reimbursement code. Interview candidates on how they would handle a specific regulatory delay or a negative clinical study - if they can't answer, move on.

How does a fractional CRO build pipeline for a medical device company — figure 1

type: warning Do not expect a fractional CRO to single-handedly close deals in the first 60 days. Medical device sales cycles are long - often 6–18 months from first contact to first procedure. The CRO's job is to build a repeatable pipeline that your founder or a future full-time sales hire can close. If you need immediate revenue, you are better off hiring a contract clinical specialist or a part-time sales rep who can demo the device in person. ![How does a fractional CRO build pipeline for a medical device company — figure 3](/assets/qa/tl13203-b3.jpg) ``` ## Building Pipeline Through Clinical Evidence and Thought Leadership In 2027, the most effective pipeline generation tactic for medical devices is content that educates and builds trust with surgeons and hospital administrators. A fractional CRO will work with your clinical team to produce: - White papers or case reports summarizing early clinical outcomes

flowchart TD A[Pipeline Audit] --> B[Identify Top 30 Target Accounts] B --> C{Reimbursement & Regulatory Clear?} C -->|Yes| D[Build Clinical Evidence Package] C -->|No| E[Prioritize Regulatory Milestones] D --> F[Outreach via Email/LinkedIn/Phone] F --> G[Surgeon Meeting or Conference Intro] G --> H[Product Evaluation or Trial] H --> I[GPO Contract or Direct Purchase] I --> J[First Case/Procedure] J --> K[Reference Account & Case Study] K --> L[Scale to Next 30 Accounts]

flowchart LR A[Founder-Led Sales] --> B{Revenue Stage?} B -->|Pre-revenue to 2M| C[Fractional CRO] B -->|2M to 5M| D[Fractional CRO + Part-time Clinical Specialist] B -->|5M+| E[Full-time VP of Sales + Sales Team] C --> F[Pipeline Playbook Built] D --> F F --> G[Repeatable Process] G --> H[Scale with Full-Time Hire] Typically 2–4 weeks if the company already has clinical evidence and a target account list. If the company needs to first generate clinical data or secure regulatory clearance, it can take 3–6 months before any outbound activity makes sense. What if my device is still in clinical trials or pre-FDA clearance? A fractional CRO can still help by building relationships with KOLs, preparing for conference presence, and developing a pre-launch pipeline. However, they cannot generate revenue until the device is cleared. Focus on clinical evidence generation and early adopter identification. Do I need to give the fractional CRO equity? Rarely. Most fractional CROs work on a cash retainer basis. Some may accept a small equity component (0.5–2%) in lieu of higher cash compensation, but this is more common for pre-revenue companies. For a medical device company with some revenue, expect a pure cash arrangement. Can a fractional CRO work remotely, or do they need to be local? They can work remotely, but they should be willing to travel to key conferences (2–4 per year) and to your company's location for initial onboarding and quarterly reviews. Many fractional CROs are based in major medical device hubs (Minneapolis, Boston, Southern California) and can leverage their local networks. ## Related on PULSE - [Is there a fractional CRO available near me in Pasadena in 2027?](/knowledge/tl12271)

Download:
Was this helpful?  
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territory